18F-FDG PET/CT compared to conventional imaging modalities in pediatric primary bone tumors

Pediatric Radiology

Volumn 42, Issue 4, 2012, Pages 418-430

  London, Kevin ^a,b   Stege, Claudia ^c   Cross, Siobhan ^a   Onikul, Ella ^a   Graf, Nicole ^a   Kaspers, Gertjan ^c   Dalla Pozza, Luciano ^a   Howman Giles, Robert ^b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone neoplasm; Ewing sarcoma; FDG; Osteosarcoma; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; ARTICLE; BONE SCINTISCANNING; BONE TUMOR; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG LESION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; TUMOR VOLUME; AUSTRALIA; COMPARATIVE STUDY; INFANT; PREVALENCE; REPRODUCIBILITY; STATISTICS; TREATMENT OUTCOME;

ADOLESCENT; AUSTRALIA; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFANT; MALE; POSITRON-EMISSION TOMOGRAPHY; PREVALENCE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84863525347     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-011-2278-x     Document Type: Article

References (29)

1. Howman-Giles R, Hicks RJ, McCowage G et al (2006) Primary bone tumors. In: Charron M (ed) Practical pediatric PET imaging. Springer, New York
2. Bielack SS, Kempf-Bielack B, Delling G et al (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20:776-790
3. Saifuddin A (2002) The accuracy of imaging in the local staging of appendicular osteosarcoma. Skeletal Radiol 31:191-201
4. Brisse H, Ollivier L, Edeline V et al (2004) Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment. Pediatr Radiol 34:595-605
5. Bastiaannet E, Groen H, Jager PL et al (2004) The value of FDGPET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev 30:83-101
6. Franzius C, Daldrup-Link HE,Wagner-Bohn A et al (2002) FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging. Ann Oncol 13:157-160
7. Bredella MA, Caputo GR, Steinbach LS et al (2002) Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas. AJR 179:1145-1150
8. 18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma. J Nucl Med 50:340-347
9. Schuetze SM, Rubin BP, Vernon C et al (2005) Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy. Cancer 103:339-348
10. McCarville MB, Christie R, Daw NC et al (2005) PET/CT in the evaluation of childhood sarcomas. AJR 184:1293-1304
11. Volker T, Denecke T, Steffen I et al (2007) Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol 25:5435-5441
12. Lowrey R Clinical calculator 1. http://faculty.vassar.edu/lowry/clin1. html. Accessed November 2010
13. Franzius C, Daldrup-Link HE, Sciuk J et al (2001) FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Ann Oncol 12:479-486
14. 18F-FDG PET versus noduleenhancement CT. AJR 187:1361-1367
15. Deeks JJ, Altman DG (2004) Diagnostic tests 4: likelihood ratios. BMJ 329:168-169
16. Peat J, Barton B (2005) In: Medical statistics: a guide to data analysis and critical appraisal, 1st edn. Blackwell, Malden, MA, pp 285-286
17. 18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial. J Clin Oncol 27:4385-4391
18. 18F-FDG PET and MRI. J Nucl Med 50:1435-1440
19. Davis AM, Bell RS, Goodwin PJ (1994) Prognostic factors in osteosarcoma: a critical review. J Clin Oncol 12:423-431
20. Franzius C, Sciuk J, Brinkschmidt C et al (2000) Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clin Nucl Med 25:874-881
21. Schulte M, Brecht-Krauss D, Werner M et al (1999) Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET. J Nucl Med 40:1637-1643
22. 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors. J Nucl Med 49:1038-1046. doi:10.2967/jnumed.107.050187
23. Eary JF, O'Sullivan F, Powitan Y et al (2002) Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis. Eur J Nucl Med Mol Imaging 29:1149-1154
24. Franzius C, Bielack S, Flege S et al (2002) Prognostic significance of (18)F-FDG and (99 m)Tc-methylene diphosphonate uptake in primary osteosarcoma. J Nucl Med 43:1012-1017
25. Hamada K, Tomita Y, Inoue A et al (2009) Evaluation of chemotherapy response in osteosarcoma with FDG-PET. Ann Nucl Med 23:89-95
26. Hawkins DS, Conrad EU 3rd, Butrynski JE et al (2009) [F-18]- fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults. Cancer 115:3519-3525
27. 18F] Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. J Clin Oncol 23:8828-8834
28. Panuel M, Gentet JC, Scheiner C et al (1993) Physeal and epiphyseal extent of primary malignant bone tumors in childhood. Correlation of preoperative MRI and the pathologic examination. Pediatr Radiol 23:421-424
29. Bossuyt PM, Reitsma JB, Bruns DE et al (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Radiol 58:575-580